Savara Inc.
- SVRA
- NASDAQ
- Biotechnology
- Rare Respiratory Diseases
- Inhaled GM-CSF Therapy
$4.45
Today −6.12%Quote Oct 16, 2026, 08:00 PM UTC
−17.90%over the last month
Max drawdown −18.3%From 1-month high −18.3%3 months −18.9%
Our viewPro
The call stays with Pro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
Market value
$914.3M
Quote Oct 16
Next earnings
Nov 11
Expected, not confirmed
Analyst target
$10.00
+124.7% from here
Floor
$4.41
1.0% below price
Where the price sits
No analyst target range for this stock.
The call stays with Pro
7 locked chapters- What to do with this namePro
- Why nowPro
- Why this stockPro
- Section write-upsPro
- Story timelinePro
- News briefPro
- Ask about SVRAPro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
Log in — 14 days freeWhere the money comes from
No revenue split by segment on file.
Industry
Biotechnology
Employees
70